Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2017

Mar 15, 2017

33899_dirs_2017-03-15_bc2eaf59-dc2e-4264-a180-bd89a3dbaf6c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2017-03-13

Reporting Person: HARTWIG JORGENE K. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-13 Common Stock M 1666 $27.68 Acquired 8975 Direct
2017-03-13 Common Stock M 833 $28.59 Acquired 9808 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-13 Stock Option $27.68 M 1666 Disposed 2026-02-04 Common Stock (1666) Direct
2017-03-13 Stock Option $28.59 M 833 Disposed 2025-02-17 Common Stock (833) Direct

Footnotes

F1: These retention stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, vest in three equal annual installments beginning on 2/4/2017

F2: These retention stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, vest in three equal annual installments, beginning on 2/17/2016